ALC
NYSE · Health Care
Alcon Inc
$66.12
+0.94 (+1.44%)
Financial Highlights (FY 2026)
Revenue
8.40B
Net Income
791.91M
Gross Margin
56.3%
Profit Margin
9.4%
Rev Growth
+6.1%
D/E Ratio
0.24
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 56.3% | 56.3% | 40.6% | 40.6% |
| Operating Margin | 13.1% | 11.8% | 20.2% | 20.8% |
| Profit Margin | 9.4% | 9.0% | 16.1% | 14.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 8.40B | 7.92B | 7.70B | 7.03B |
| Gross Profit | 4.73B | 4.46B | 3.13B | 2.85B |
| Operating Income | 1.10B | 931.45M | 1.56B | 1.46B |
| Net Income | 791.91M | 671.99M | 1.24B | 1.01B |
| Gross Margin | 56.3% | 56.3% | 40.6% | 40.6% |
| Operating Margin | 13.1% | 11.8% | 20.2% | 20.8% |
| Profit Margin | 9.4% | 9.0% | 16.1% | 14.4% |
| Rev Growth | +6.1% | +6.1% | -7.0% | +7.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.49B | 2.49B | 2.74B | 2.61B |
| Total Equity | 10.48B | 10.48B | 21.87B | 25.67B |
| D/E Ratio | 0.24 | 0.24 | 0.13 | 0.10 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.51B | 1.35B | 1.98B | 1.80B |
| Free Cash Flow | — | — | 976.52M | 785.68M |